Share-Based Compensation Using Stock Acquisition Rights for Officers
First written in FY2017-Q2. 11 of 14 entries say "Advanced", first in FY2018-Q2. Latest entry: 2026-08-06.
15 other companies' latest entry also says "Advanced".
- FY2026AdvancedAnnual report
「Based on the recommendation and the amounts of individual performance-based compensation calculated by the President for each individual, excluding the Chairperson and President, the Board of Directors determined the amounts of compensation and other payments in June 2025. In July 2025, it also resolved to deliver restricted stock through the disposal of treasury shares and to grant units under the performance-linked restricted stock compensation plan.」
In FY2025, the Company implemented the RS and PSU plans introduced in place of stock-based compensation stock options, using ROE, employee engagement, customer orientation and GHG emissions reduction as PSU metrics. - FY2025ReframedAnnual report
「As the Company transitioned in June 2024 from its stock-based compensation stock option plan to a restricted stock compensation plan, there are no applicable matters for the consolidated fiscal year.」
The Company transitioned officer share-based compensation from the previous plan centered on stock acquisition rights to restricted stock compensation comprising RS and PSU. - FY2024-Q2AdvancedAnnual report
「The Company issued stock acquisition rights during the second quarter accounting period.」
For the issue dated 9 August 2023, the Company issued 892 stock acquisition rights, representing 89,200 underlying shares, to 7 directors and 19 executive officers and fellows. The exercise period runs from 10 August 2023 to 9 August 2053. - FY2023AdvancedAnnual report
「FY2022 stock acquisition rights: categories and number of grantees: Company directors: 8; Company executive officers and fellows: 19; number of stock options by class of shares: common shares: 102,900」
For FY2022, the Company granted stock acquisition rights representing 102,900 common shares to 8 directors and 19 executive officers and fellows. - FY2023-Q2AdvancedAnnual report
「The Company issued stock acquisition rights during the second quarter accounting period.」
On 22 August 2022, the Company issued 1,029 stock acquisition rights, representing 102,900 underlying shares, to 8 directors and 19 executive officers and fellows. The exercise period runs from 23 August 2022 to 22 August 2052. - FY2022-Q2AdvancedAnnual report
「The Company issued stock acquisition rights during the second quarter accounting period.」
For the issue dated 17 August 2021, the Company issued 1,240 stock acquisition rights, representing 124,000 underlying shares, to 7 directors and 19 executive officers and fellows. The exercise period runs from 18 August 2021 to 17 August 2051. - FY2021-Q2AdvancedAnnual report
「The Company issued stock acquisition rights during the second quarter accounting period.」
On 18 August 2020, the Company issued 2,233 stock acquisition rights, representing 223,300 underlying shares, to 6 directors and 21 executive officers and fellows. The exercise period runs from 19 August 2020 to 18 August 2050. - FY2020-Q2AdvancedAnnual report
「The Company issued stock acquisition rights during the second quarter accounting period.」
The Company issued 1,047 stock acquisition rights, representing 104,700 underlying shares, to 6 directors and 19 executive officers and fellows. The exercise period runs from 21 August 2019 to 20 August 2049. - FY2019-Q2AdvancedAnnual report
「The Company issued stock acquisition rights during the second quarter accounting period.」
The Company issued 897 stock acquisition rights, representing 89,700 underlying shares, to 8 directors and 20 executive officers. The exercise period runs from 21 August 2018 to 20 August 2048. - FY2018-Q2AdvancedAnnual report
「The Company issued stock acquisition rights during the second quarter accounting period.」
The Company issued 722 stock acquisition rights, representing 72,200 underlying shares, to officers. The exercise period runs from 22 August 2017 to 21 August 2047. - FY2017RestatedAnnual report
「FY2016 stock acquisition rights: categories and number of grantees: Company directors, excluding outside directors: 8; Company executive officers: 18; common shares: 68,200; exercise period: from 23 August 2016 to 22 August 2046」
The filing confirms the details of the prior year's stock-based compensation stock options for officers, including the eligible recipients, 68,200 shares and the exercise period. - FY2017-Q2First statedAnnual report
「The Company issued stock acquisition rights during the second quarter accounting period.」
The Company issued 682 stock acquisition rights, representing 68,200 underlying shares, to directors, executive officers and audit & supervisory board members. The exercise price is ¥1 per share, and the exercise period runs from 23 August 2016 to 22 August 2046.